Globally, 788 million adults live with chronic kidney disease. For most, peritoneal dialysis remains out of reach, held back by the cost and logistics of pre-filled consumables.

KarePD is building a new standard for peritoneal dialysis, generating pharmaceutical-grade dialysate on demand from tap water, at the point of care. One integrated platform for automated therapy and connected monitoring, built to serve every patient from infant to adult, reducing the consumable burden by ~97%.